Dr. Hunter has a love for mentoring, teaching, advocating, and the overall wellbeing of children and their families. She has lead the Food Insecurity Taskforce, which began a screening and connection to resources program in the Primary Care Clinic. She supervises residents at the Vanderbilt Primary Care Clinic and Vanderbilt Newborn Nursery. She also directs the Community Health and Advocacy Rotation for PGY-2 residents and the Social Medicine and Advocacy Academic Community for the pediatric residency program at Vanderbilt.

Dr. Hunley is a clinician in the Division of Pediatric Nephrology & Hypertension where he cares for kidney related diseases in kids from neonates to young adults. His interests include glomerular disease, Hemolytic Uremic Syndrome, kidney stones and pediatric hypertension including obesity -related. His research endeavors are directed at better understanding and treating these entities. Dr. Hunley is the Vanderbilt Pediatrics site Principal Investigator for CureGN, (Cure Glomerulonephropathy; www.CureGN.org) a multicenter National Institute of Health (NIH)-funded consortium working collaboratively to recruit and follow a large cohort of participants with Minimal Change Disease, FSGS, Membranous Nephropathy, and IgA Nephropathy. An underlying hypothesis is that different disease mechanisms can result in similar pathologic and clinical phenotypes, but different disease courses. Identifying and characterizing these mechanisms will have broad influence on diagnostic classification, accurate prognostication, definition of patient cohorts for clinical trials, and identification of individualized therapies.

>> View Publications on PubMed

Dr. Hundley's research has included clinical diagnosis of Autism Spectrum Disorder (ASD), sleep disturbance in children with ASD, and genetic linkages to multiple developmental disorders.

Dr. Hummell is retired from clinical practice and is no longer accepting patients. She provides consultative service to the Center for Disease Control and Prevention, Clinical Immunization Safety Assessment Program.

Dr. Howard has extensive experience working in international settings and in clinical and observational global health research. Her current research focuses on pneumococcal colonization dynamics in young children, and the impact of these dynamics, as well as the impact of viral and bacterial vaccines, on the development of pneumonia and respiratory illnesses in children living in rural and resource-limited settings.

>> View Publications on PubMed

Dr. Ho's research is centered in cancer pharmacology with background knowledge in molecular pharmacology, clinical pharmacology and molecular biology. His main areas of research include 1) mechanisms by which drug transporters contribute to overall chemotherapy disposition in pediatric oncology and 2) pharmacogenomics in cancer therapy. He earned a medical degree in 1997 and a Master of Science in Clinical Investigation in 2004, both from Vanderbilt University School of Medicine. He completed a pediatrics residency in the Department of Pediatrics in 2000, a clinical fellowship in the Division of Pediatric Hematology/Oncology at Vanderbilt Children's Hospital, and a research fellowship in the Division of Clinical Pharmacology at Vanderbilt University Medical Center in 2003. He received a Vanderbilt University School of Medicine Clinician Scientist Award in 2003, a K08 Clinical Scientist Career Development Award from NIH (NIGMS) in 2007, and a R01 Independent Investigator Award from NIH (NIGMS) in 2012, and has served as co-investigator on several NIH-funded grants focused on drug transporters, drug disposition, pharmacogenetics, and clinical pharmacology. Dr. Ho was elected to the Society for Pediatric Research in 2010 and awarded a Presidential Early Career Award for Scientists and Engineers (PECASE) from NIH and the White House Office of Science and Technology Policy in 2013. This award, established in 1996, is the highest honor bestowed by the United States government on science and engineering professionals in the early stages of their independent research careers and reflect the administration's priority "on producing outstanding scientists and engineers to advance the nation's goals, tackle grand challenges, and contribute to the American economy." He joined the faculty at Monroe Carell Jr. Children's Hospital at Vanderbilt in 2003 and is board certified by the American Board of Pediatrics in Pediatric Hematology-Oncology.

>> View Publications on PubMed

As a board-certified Pediatrician and a Pediatric Gastroenterologist, Dr. Hiremath is an internationally recognized leader in eosinophilic gastrointestinal diseases (EGIDs), bringing nearly fifteen years of clinical and research experience to advance patient care and scientific discovery.

At Vanderbilt, Dr. Hiremath directs the multidisciplinary Pediatric EGID program, a leading referral center for EGID patients across the Southern region. His clinic is dedicated to delivering evidence-based, compassionate care while addressing unique challenges faced by the children and families living with these complex conditions. Dr. Hiremath’s dedication to his patients and their families has earned him accolades, such as the Health Care Hero Award from Vanderbilt’s Friends of Children’s Hospital. Guided by meaningful interactions and shared decision-making, he identifies unmet needs that shape his translational research program.

Dr. Hiremath’s interdisciplinary translational research integrates pathology, allergy and immunology, biomedical engineering, computer science, industry partners, and patient care. As an active member of the NIH-funded Consortium of Eosinophilic Gastrointestinal Disease Researchers (CEGIR) he collaborates with global leaders in the field. Grants from NIH, the American College of Gastroenterology, and institutional programs support his research. He has authored/ co-authored over 80 peer-reviewed manuscripts and has been invited to present at numerous national and international meetings. He is deeply committed to mentoring students, residents, and fellows and fostering the next generation of leaders.

>> View Publications on PubMed

Schematic illustration of the multidisciplinary clinical and research endeavors to advance the field of EGIDs (including EoE)

Dr. Hine's current research and clinical interests include integration of behavioral-health services into pediatric primary care practices, early identification and treatment of autism spectrum disorder within primary care, and use of telemedicine to enhance treatment and support for children with behavioral-health concerns and their families.

>> View Publications on PubMed